Sentrx delivers comprehensive pharmacovigilance solutions for clinical trial safety, post-marketing safety surveillance and risk management programs. Drug Safety Services from Sentrx help pharmaceutical, biotechnology, medical device, consumer health and dietary supplement companies document the safety profile of their products during clinical development and post-approval, enabling clients to minimize risk and maximize benefits.
In addition to finely tuned adverse event reporting processes, Sentrx provides Safety Data Services, offering companies of every size access to the most advanced safety database technology and expertise available in the industry. With Safety System Hosting, Sentrx manages all aspects of pharmacovigilance data, from configuration to validation to international reporting.
The unique Sentrx business model allows clients to choose the level of access, control and support necessary to meet their international adverse event reporting requirements.
Sentrx secures US$3 million financing from MMV Financial